Connectivity Challenges in the Pharmaceutical Industry: A Case Study
The article highlights the complexity of innovative processes and their demands on individual abilities using the example of market access for innovative pharmaceuticals, which she explains in detail. At a time when innovative companies must find flexible solutions to ever-changing market dynamics, the ability of connectivity constitutes a key success factor. Companies’ strategic orientation and the operational goals of individual employees require continuous review and (re-)alignment. In the era of connectivity, strategies, organizational structures, and connected tasks of single employees must enable agility in order to create successful innovative processes.
- Efpia. (2017). Retrieved from https://www.efpia.eu/about-medicines/use-of-medicines/hta-relative-efficacy-assessment/
- EUnetHTA. (2017). Retrieved from http://www.eunethta.eu/activities/joint-action-3/jointaction31/eunethta-joint-action-3-2016-2020
- European Commission. (2013). Retrieved from http://ec.europa.eu/health//sites/health/files/systems_performance_assessment/docs/erp_reimbursement_medicinal_products_en.pdf